Cargando…

The Use of Exenatide in Managing Markers of Cardiovascular Risk in Patients with Type 2 Diabetes: A Systematic Review

Objective: This review examines the use of exenatide twice daily in managing changes in markers of cardiovascular risk in patients with type 2 diabetes. Background: Type 2 diabetes is a progressive metabolic disorder, which results from defects in insulin secretion and/or insulin action leading to c...

Descripción completa

Detalles Bibliográficos
Autor principal:	Ojo, Omorogieva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086680/ https://www.ncbi.nlm.nih.gov/pubmed/27669277 http://dx.doi.org/10.3390/ijerph13100941

Ejemplares similares

The Association of Planetary Health Diet with the Risk of Type 2 Diabetes and Related Complications: A Systematic Review
por: Ojo, Omorogieva, et al.
Publicado: (2023)

Evaluation of the Role of Enteral Nutrition in Managing Patients with Diabetes: A Systematic Review
por: Ojo, Omorogieva, et al.
Publicado: (2014)

The Effect of Dietary Fibre on Gut Microbiota, Lipid Profile, and Inflammatory Markers in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
por: Ojo, Omorogieva, et al.
Publicado: (2021)

Dietary Intake and Type 2 Diabetes
por: Ojo, Omorogieva
Publicado: (2019)

Exenatide Use in the Management of Type 2 Diabetes Mellitus
por: Kyriacou, Angelos, et al.
Publicado: (2010)

The Efficacy of Tele-Monitoring in Maintaining Glycated Haemoglobin Levels in Patients with Type 2 Diabetes Mellitus: A Systematic Review
por: Emonena, Hope, et al.
Publicado: (2022)

The Effects of Almonds on Gut Microbiota, Glycometabolism, and Inflammatory Markers in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
por: Ojo, Omorogieva, et al.
Publicado: (2021)

Exenatide Once Weekly for Management of Type 2 Diabetes: A Review
por: Inaishi, Jun, et al.
Publicado: (2022)

A Review of Exenatide: Optimizing Glycemic Control and Associated Cardiovascular Risk Factors in Type 2 Diabetes
por: Htike, Zin Z., et al.
Publicado: (2012)

The Effect of Dietary Glycaemic Index on Glycaemia in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Ojo, Omorogieva, et al.
Publicado: (2018)

The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome
por: Dawson, Alison J., et al.
Publicado: (2019)

The Role of Dietary Fibre in Modulating Gut Microbiota Dysbiosis in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
por: Ojo, Omorogieva, et al.
Publicado: (2020)

South Indian Cuisine with Low Glycemic Index Ingredients Reduces Cardiovascular Risk Factors in Subjects with Type 2 Diabetes
por: Pavithran, Nivedita, et al.
Publicado: (2020)

Diabetic Retinopathy Screening: A Systematic Review on Patients’ Non-Attendance
por: Kashim, Rahima Muhammad, et al.
Publicado: (2018)

The Effects of a Low GI Diet on Cardiometabolic and Inflammatory Parameters in Patients with Type 2 and Gestational Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
por: Ojo, Omorogieva, et al.
Publicado: (2019)

The Effect of Prebiotics and Oral Anti-Diabetic Agents on Gut Microbiome in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis of Randomised Controlled Trials
por: Ojo, Omorogieva, et al.
Publicado: (2022)

Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study
por: Simó, Rafael, et al.
Publicado: (2015)

The Effect of Diabetes-Specific Enteral Nutrition Formula on Cardiometabolic Parameters in Patients with Type 2 Diabetes: A Systematic Review and Meta–Analysis of Randomised Controlled Trials
por: Ojo, Omorogieva, et al.
Publicado: (2019)

The Impact of Opium Abuse on Lipid Profile in Patients with Diabetes: A Systematic Review and Meta-Analysis
por: Ojo, Omorogieva, et al.
Publicado: (2019)

Enteral Nutrition in Dementia: A Systematic Review
por: Brooke, Joanne, et al.
Publicado: (2015)

The Use of Enteral Nutrition in the Management of Stroke
por: Ojo, Omorogieva, et al.
Publicado: (2016)

Evaluation of the Accuracy of Capillary Hydroxybutyrate Measurement Compared with Other Measurements in the Diagnosis of Diabetic Ketoacidosis: A Systematic Review
por: Brooke, Joanne, et al.
Publicado: (2016)

Exenatide improves cardiovascular risk factors in obese patients with type 2 diabetes mellitus: a prospective study
por: KÖSEOĞLU, Derya, et al.
Publicado: (2021)

The Effects of Substance Abuse on Blood Glucose Parameters in Patients with Diabetes: A Systematic Review and Meta-Analysis
por: Ojo, Omorogieva, et al.
Publicado: (2018)

Association among weight change, glycemic control, and markers of cardiovascular risk with exenatide once weekly: a pooled analysis of patients with type 2 diabetes
por: Blonde, Lawrence, et al.
Publicado: (2015)

A review of exenatide as adjunctive therapy in patients with type 2 diabetes
por: Robles, Gisela I, et al.
Publicado: (2009)

Recent Advances in Nutrition and Diabetes
por: Ojo, Omorogieva
Publicado: (2021)

Once-Weekly Exenatide in Youth With Type 2 Diabetes
por: Tamborlane, William V., et al.
Publicado: (2022)

Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetes
por: Gastaldelli, Amalia, et al.
Publicado: (2019)

The Effects of COVID-19 Lockdown on Glycaemic Control and Lipid Profile in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
por: Ojo, Omorogieva, et al.
Publicado: (2022)

Efficacy and safety of exenatide once‐weekly vs exenatide twice‐daily in Asian patients with type 2 diabetes mellitus
por: Ji, Linong, et al.
Publicado: (2013)

Efficacy and safety of once‐weekly exenatide after switching from twice‐daily exenatide in patients with type 2 diabetes
por: Watanabe, Yuusuke, et al.
Publicado: (2019)

The Effects of Exenatide Once Weekly (EXQW) and Exenatide Twice a Day (EXBID) on Beta-Cell Function in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
por: Wang, Jie, et al.
Publicado: (2019)

Efficacy and tolerability of the new autoinjected suspension of exenatide once weekly versus exenatide twice daily in patients with type 2 diabetes
por: Wysham, Carol H., et al.
Publicado: (2017)

Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetes
por: Ratner, Robert, et al.
Publicado: (2011)

Evaluating the Association between Diabetes, Cognitive Decline and Dementia
por: Ojo, Omorogieva, et al.
Publicado: (2015)

Metabolic Effects of the Incretin Mimetic Exenatide in the Treatment of Type 2 Diabetes
por: Schnabel, Catherine A, et al.
Publicado: (2006)

Effects of Exenatide in a Morbidly Obese Patient with Type 2 Diabetes
por: Kishimoto, Miyako, et al.
Publicado: (2014)

Emerging utility of once-weekly exenatide in patients with type 2 diabetes
por: Goud, Aditya, et al.
Publicado: (2015)

Effects of Exenatide on Coagulation and Platelet Aggregation in Patients with Type 2 Diabetes
por: Zhang, Yaqin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eqj41so7pt4s2ch5rnqcmp3puu